Quick Answer
Strata Critical Medical, Inc. reported Diluted EPS of $0.50 per share for fiscal year 2025.
Strata Critical Medical, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.50 | +242.9% |
| 2024 | -$0.35 | +53.9% |
| 2023 | -$0.76 | -100.0% |
| 2022 | -$0.38 | +59.1% |
| 2021 | -$0.93 | -132.5% |
| 2020 | -$0.40 | +7.0% |
| 2019 | -$0.43 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.70 | +2433.3% | +1500.0% |
| June 30, 2025 | -$0.05 | +66.7% | -25.0% |
| March 31, 2025 | -$0.04 | +33.3% | -33.3% |
| September 30, 2024 | -$0.03 | — | +80.0% |
| June 30, 2024 | -$0.15 | +11.8% | -150.0% |
| March 31, 2024 | -$0.06 | +57.1% | — |
| September 30, 2023 | $0.00 | +100.0% | +100.0% |
| June 30, 2023 | -$0.17 | -270.0% | -21.4% |
- Strata Critical Medical, Inc. showed an increase of +242.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Strata Critical Medical, Inc.’s diluted eps has grown by 216.3% (from $0.43 per share (loss) to $0.50 per share).
- The most recent figure is from Strata Critical Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: